Jefferies Maintains Buy on Insulet, Lowers Price Target to $190
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $275 to $190.
Jefferies analyst Matthew Taylor maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price target from $275 to $190.